Literature DB >> 17495722

Cost-utility analysis of emergency department thoracotomy for trauma victims.

Todd B Brown1, Marcus Romanello, Meredith Kilgore.   

Abstract

BACKGROUND: Our objective was to assess the cost-effectiveness of emergency department thoracotomy (EDT) performed on both penetrating and blunt trauma victims, using both published survival and outcome data and previously unaccounted for data on the cost of occupational exposure.
METHODS: Cost-utility analysis was performed using decision-analytic models constructed for both penetrating and blunt trauma scenarios. Survival and impairment data, the rates and costs of occupational exposure, and the utilities of neurologic impairment and provider seroconversion were all based on published literature. Costs of EDT were estimated using the National Inpatient Sample (NIS) from the Health Care Utilization Project database. One-way sensitivity analyses on input parameters and probabilistic sensitivity analyses using Monte Carlo simulations were performed.
RESULTS: The incremental cost-effectiveness ratio of EDT for penetrating trauma was $16,125 per quality-adjusted life year (QALY), and less than $50,000 per QALY with a 93.4% probability. The incremental cost-effectiveness ratio for blunt trauma was $163,136 per QALY, and less than $50,000 per QALY with a 37% probability. Neither model was sensitive to provider exposure. The penetrating model was insensitive to the probability of neurologically intact survival, the utility adjustment, procedure costs, and long-term care. The blunt model was sensitive to the probabilities of survival and of neurologic impairment.
CONCLUSIONS: EDT is cost-effective for penetrating trauma, and not cost-effective for blunt trauma given current rates of survival and impairment. Occupational exposure does not significantly impact the cost-effectiveness of the procedure.

Entities:  

Mesh:

Year:  2007        PMID: 17495722     DOI: 10.1097/01.ta.0000235951.21584.a0

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  7 in total

Review 1.  Resuscitative thoracotomy in penetrating trauma.

Authors:  Lindsay M Fairfax; Li Hsee; Ian D Civil
Journal:  World J Surg       Date:  2015-06       Impact factor: 3.352

Review 2.  Survival after emergency department thoracotomy in the pediatric trauma population: a review of published data.

Authors:  Eliza E Moskowitz; Clay Cothren Burlew; Ann M Kulungowski; Denis D Bensard
Journal:  Pediatr Surg Int       Date:  2018-06-06       Impact factor: 1.827

3.  Understanding Emergency Care Delivery Through Computer Simulation Modeling.

Authors:  Lauren F Laker; Elham Torabi; Daniel J France; Craig M Froehle; Eric J Goldlust; Nathan R Hoot; Parastu Kasaie; Michael S Lyons; Laura H Barg-Walkow; Michael J Ward; Robert L Wears
Journal:  Acad Emerg Med       Date:  2017-09-21       Impact factor: 3.451

4.  Emergency Department Thoracotomy: Development of a Reliable, Validated Checklist for Procedural Training.

Authors:  Hashim Q Zaidi; Sarah S Dhake; Danielle T Miller; Priyanka Sista; Matthew J Pirotte; Abra L Fant; David H Salzman
Journal:  AEM Educ Train       Date:  2019-09-12

5.  Outcomes and indications for emergency thoracotomy after adoption of a more liberal policy in a western European level 1 trauma centre: 8-year experience.

Authors:  Edoardo Segalini; Luca Di Donato; Arianna Birindelli; Alice Piccinini; Alberto Casati; Carlo Coniglio; Salomone Di Saverio; Gregorio Tugnoli
Journal:  Updates Surg       Date:  2018-12-26

6.  A one-year cost-utility analysis of REBOA versus RTACC for non-compressible torso haemorrhage.

Authors:  Maxwell S Renna; Cristiano van Zeller; Farah Abu-Hijleh; Cherlyn Tong; Jasmine Gambini; Mengyao Ma
Journal:  Trauma       Date:  2017-11-24

7.  Comparative Effectiveness of Emergency Resuscitative Thoracotomy versus Closed Chest Compressions among Patients with Critical Blunt Trauma: A Nationwide Cohort Study in Japan.

Authors:  Kodai Suzuki; Shigeaki Inoue; Seiji Morita; Nobuo Watanabe; Ayumi Shintani; Sadaki Inokuchi; Shinji Ogura
Journal:  PLoS One       Date:  2016-01-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.